NEC


Associated tags: Safety, Value, NEC, TSE

Locations: SOUTH AFRICA, AFRICA, USA, TEXAS, SPAIN, INDONESIA, VIETNAM, MALAYSIA, GERMANY, DISTRICT OF COLUMBIA, FLORIDA, MILFORD, MA, US, CA, SINGAPORE, BERLIN, NEW YORK CITY, NEW YORK, AR, TOKYO, JAPAN

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024

Retrieved on: 
Tuesday, April 9, 2024

Extensive Phase I immunology data confirm strong immunogenicity of TG4050 in the adjuvant treatment of head and neck cancers.

Key Points: 
  • Extensive Phase I immunology data confirm strong immunogenicity of TG4050 in the adjuvant treatment of head and neck cancers.
  • These data are highlighted in the AACR press conference being held today and in a poster presentation which will take place tomorrow, April 10, at 9:00 a.m. PDT.
  • Key findings of the poster include:
    All 16 patients who received TG4050 are disease free after a median 18.6-month follow-up.
  • TG4050 is now starting to show a potential benefit for head and neck cancer patients at high risk of relapse.

NEC and Skyloom to Pioneer 100 Gbps Space Optical Communications, Transforming Global Internet Connectivity

Retrieved on: 
Tuesday, March 19, 2024

TOKYO and DENVER, March 19, 2024 /PRNewswire-PRWeb/ -- NEC Corporation (NEC; TSE: 6701) and Skyloom Global Corporation have joined forces to revolutionize space communications with the development of cutting-edge optical communication equipment for multi-orbit satellite networks. The collaboration aims to commercialize and make available on the open market one of the world's fastest space optical terminals, achieving remarkable high-speed inter-satellite communications of 100 Gbps and more, propelling the space industry into a new era of connectivity.

Key Points: 
  • TOKYO and DENVER, March 19, 2024 /PRNewswire-PRWeb/ -- NEC Corporation (NEC; TSE: 6701) and Skyloom Global Corporation have joined forces to revolutionize space communications with the development of cutting-edge optical communication equipment for multi-orbit satellite networks.
  • "In partnership with NEC, we are committed to the joint development, testing, and manufacturing of the groundbreaking 100 Gbps WARP Optical Communications Terminal (OCT), slated for completion by the end of 2025.
  • In anticipation of this demand growth, NEC and Skyloom are at the forefront of developing technology to achieve optical communication speeds of 100 Gbps and higher.
  • "We expect that our collaboration with Skyloom on space optical communication will contribute to expanding space utilization in the era of networked satellite constellations."

NEC and Sumitomo Corporation Sign Strategic Partnership Agreement to Expand Global Sales of the CropScope Agricultural ICT Platform

Retrieved on: 
Monday, March 4, 2024

TOKYO, Mar 4, 2024 - (ACN Newswire) - NEC Corporation (TSE: 6701) and Sumitomo Corporation (Sumitomo) have signed a strategic partnership agreement to expand global sales of NEC's agricultural ICT platform CropScope.

Key Points: 
  • TOKYO, Mar 4, 2024 - (ACN Newswire) - NEC Corporation (TSE: 6701) and Sumitomo Corporation (Sumitomo) have signed a strategic partnership agreement to expand global sales of NEC's agricultural ICT platform CropScope.
  • Based on this partnership, NEC and Sumitomo aim to develop markets mainly in South America and the ASEAN region by utilizing Sumitomo's global network.
  • Through this partnership, CropScope is initially being introduced on a trial basis to major sugar companies in Thailand and Brazil.
  • Through this partnership, Sumitomo will utilize its global network to expand CropScope's sales area to Thailand, Brazil, and India, aiming for business growth.

Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050

Retrieved on: 
Tuesday, March 5, 2024

BostonGene is partnering with NEC and Transgene to continue performing tumor molecular profiling and microenvironment analysis and provide high-throughput sequencing services.

Key Points: 
  • BostonGene is partnering with NEC and Transgene to continue performing tumor molecular profiling and microenvironment analysis and provide high-throughput sequencing services.
  • The partnership with BostonGene will enable fast turnaround of next-generation sequencing (NGS) data, and sophisticated analytics will enable comprehensive profiling of patient immune contexture.
  • “Our collaboration with BostonGene has provided in-depth information on patient phenotypes in the Phase I trial.
  • “We are committed to supporting Transgene and NEC as they advance these clinical trials,” said Nathan Fowler, MD, Chief Medical Officer at BostonGene.

SoftBank Corp., NEC and Broadcom Jointly Validate RAN Modernization with Virtualization by Unifying O-RAN Architecture and Telco Cloud

Retrieved on: 
Thursday, February 29, 2024

The companies confirmed the feasibility of RAN modernization by converging O-RAN architecture (1) and Telco Cloud (2).

Key Points: 
  • The companies confirmed the feasibility of RAN modernization by converging O-RAN architecture (1) and Telco Cloud (2).
  • In this joint verification, a virtualized RAN (“vRAN”) system consisted of a general-purpose common infrastructure defined by SoftBank, vRAN applications using O-RAN architecture by NEC, and a vRAN platform optimized for VMware’s Telco Cloud platform.
  • We believe that the innovative RAN modernization with virtualization, O-RAN, and Telco Cloud that we have verified will be the core technology for efficient RAN operations in the future.
  • PaaS(“VMware Telco Cloud Automation”)and its integrated orchestration capabilities enable operators to quickly deploy rapidly evolving CNF (“cloud-native function”) requirements for NEC's RAN deployments."

DOCOMO and NEC to Establish “OREX SAI” Joint Venture to Provide OREX Packages for Open RAN Global Deployments

Retrieved on: 
Monday, February 26, 2024

NTT DOCOMO, INC. and NEC Corporation announced today that they plan to establish a joint venture company, OREX SAI, INC. on April 1 to provide OREX Packages solutions for the full-scale global deployment of Open RAN services.

Key Points: 
  • NTT DOCOMO, INC. and NEC Corporation announced today that they plan to establish a joint venture company, OREX SAI, INC. on April 1 to provide OREX Packages solutions for the full-scale global deployment of Open RAN services.
  • Leveraging NEC’s established business infrastructure and global network in over 50 countries and territories, the joint venture will accelerate its global expansion of Open RAN business.
  • In their collaboration with OREX PARTNERS to realize Open RAN, DOCOMO and NEC recognize the importance of optimizing local product and service delivery.
  • In response, they will now form a joint venture company to establish a global system capable of accelerating the realization of Open RAN.

NEC and D-Wave Introduce New Quantum Offerings to Australian Market

Retrieved on: 
Monday, February 19, 2024

NEC Australia and leading international quantum computing company, D-Wave Quantum Inc. (NYSE: QBTS) (D-Wave), are partnering to release two new quantum services to the Australian market, further enhancing their quantum computing offering and options for Australia’s commercial sector, federal and state governments, and academia.

Key Points: 
  • NEC Australia and leading international quantum computing company, D-Wave Quantum Inc. (NYSE: QBTS) (D-Wave), are partnering to release two new quantum services to the Australian market, further enhancing their quantum computing offering and options for Australia’s commercial sector, federal and state governments, and academia.
  • Ayala Domani, Vice President – Technology & Innovation at NEC Australia, said quantum computing has matured rapidly and will provide Australian governments and businesses with a competitive edge.
  • Vice President of Quantum Technology Evangelism at D-Wave, Murray Thom, is in Australia for the Quantum Australia 2024 Conference + Careers Fair (Quantum Australia 2024).
  • NEC and D-Wave will be jointly speaking at Quantum Australia 2024 in Sydney from 20-22 February on their shared vision for a brighter future using quantum computing.

NEC named to list of Top 100 Global Innovators by Clarivate for 13th consecutive year

Retrieved on: 
Thursday, March 7, 2024

TOKYO, Mar 7, 2024 - (JCN Newswire) - NEC Corporation (TSE: 6701) has been named to the list of Top 100 Global Innovators 2024 by Clarivate Plc., which selects companies and organizations that "sit at the very top of the global innovation ecosystem, with the most consistent above-the-bar innovation performance."

Key Points: 
  • TOKYO, Mar 7, 2024 - (JCN Newswire) - NEC Corporation (TSE: 6701) has been named to the list of Top 100 Global Innovators 2024 by Clarivate Plc., which selects companies and organizations that "sit at the very top of the global innovation ecosystem, with the most consistent above-the-bar innovation performance."
  • This is the 13th* consecutive year that NEC has been selected for the award.
  • *Only 18 organizations in the world have been selected for this award for 13 consecutive years.ShareNEC's intellectual property activities.
  • Top 100 Global Innovators 2024: https://clarivate.com/top-100-innovators/

Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050

Retrieved on: 
Tuesday, March 5, 2024

BostonGene is partnering with NEC and Transgene to continue performing tumor molecular profiling and microenvironment analysis and provide high-throughput sequencing services.

Key Points: 
  • BostonGene is partnering with NEC and Transgene to continue performing tumor molecular profiling and microenvironment analysis and provide high-throughput sequencing services.
  • The partnership with BostonGene will enable fast turnaround of next-generation sequencing (NGS) data, and sophisticated analytics will enable comprehensive profiling of patient immune contexture.
  • "Our collaboration with BostonGene has provided in-depth information on patient phenotypes in the Phase I trial.
  • "We are committed to supporting Transgene and NEC as they advance these clinical trials," said Nathan Fowler, MD, Chief Medical Officer at BostonGene.

Cisco, NEC and TIM Brazil improve TIM Brazil network quality with automation and advanced data analytics to enhance business customers experience

Retrieved on: 
Friday, March 1, 2024

The collaboration aims to improve TIM Brazil network performance, service quality and end-to-end visibility, providing an enhanced experience for customers business of all sizes.

Key Points: 
  • The collaboration aims to improve TIM Brazil network performance, service quality and end-to-end visibility, providing an enhanced experience for customers business of all sizes.
  • TIM Brazil, leading 5G mobile operator and leader in network coverage in Brazil, has identified key areas for improvement, including end-to-end visibility, automation, and network quality.
  • The company aims to continue its journey of quality improvement, offering a premium network quality and availability to its customers.
  • Our Center of Excellence (CoE) places a strong emphasis on network automation to enhance our customer's operations and network quality.